Your shopping cart is currently empty

M6766 is a selective and potent inhibitor of endoplasmic reticulum oxidoreductase 1α (ERO1α), exhibiting an IC50 of 1.4 uM and a KD of 1.1 uM. It also inhibits ERO1β with an IC50 of 7.2 uM. M6766 exerts its inhibitory effect by binding to the flavin adenine dinucleotide (FAD)-binding pocket of ERO1α. Functionally, M6766 suppresses granule secretion, αIIbβ3 integrin activation, Ca2+ mobilization, and platelet aggregation. It serves as a significant chemical probe for investigating the molecular pathways of arterial thrombosis and neurological disorders, such as ischemic stroke.


| Description | M6766 is a selective and potent inhibitor of endoplasmic reticulum oxidoreductase 1α (ERO1α), exhibiting an IC50 of 1.4 uM and a KD of 1.1 uM. It also inhibits ERO1β with an IC50 of 7.2 uM. M6766 exerts its inhibitory effect by binding to the flavin adenine dinucleotide (FAD)-binding pocket of ERO1α. Functionally, M6766 suppresses granule secretion, αIIbβ3 integrin activation, Ca2+ mobilization, and platelet aggregation. It serves as a significant chemical probe for investigating the molecular pathways of arterial thrombosis and neurological disorders, such as ischemic stroke. |
| Targets&IC50 | ERO1β:7.2 μM, ERO1α:1.4 μM |
| In vitro | M6766 selectively inhibits ERO1α (FAD-enhanced activity) without affecting MAO-A or PDI. In platelets (1–5 μM), it suppresses P-selectin exposure, αIIbβ3 activation, aggregation, and ATP secretion, while inducing ROS, annexin V binding, and disrupting ERO1α-STIM1-mediated Ca²⁺ signaling [1]. |
| In vivo | M6766 (0.3 μg/g, i.v.) prolongs occlusion time in FeCl₃-induced arterial thrombosis, reduces brain injury in ischemic stroke models, and does not prolong bleeding time [1]. |
| Molecular Weight | 360.44 |
| Formula | C19H16N6S |
| Cas No. | 696628-90-7 |
| Smiles | N#CC=1C2=NC=3C=CC=CC3N2C(SC4=NN=CN4C)=C5C1CCCC5 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.